Robeauté appointed Hannah Teichmann as Chief Clinical Officer.
Published
Signal category
People
Quote
“I have recently joined Robeauté as Chief Clinical Officer.”
— Hannah Teichmann|Robeauté team
Company
Robeauté
The world’s first microrobotic platform for the brain and new infrastructure for neuro-interventions
- Location
- Paris, FR
- Company size
- 46 employees
We are building the world's first microrobotic platform to better understand and treat brain disease. Our microrobots are designed to diagnose, treat, and monitor neurological conditions that affect more than 1 in 3 people worldwide. Our team spans passionate pluridisciplinary and multicultural inventors, engineers, and operators at the intersection of robotics, deeptech, and medicine. We are supported by leading neurosurgeons and scientific advisors, and backed by world-class investors including Plural, Cherry Ventures, and Kindred Ventures among others. Our team is growing and we are constantly on the lookout for ambitious talent and grit. If you are deeply curious, think unconventionally, work collaboratively, and want to build generational mission-critical technology that matters – we want to hear from you. Follow along on our journey and check out our open roles: https://apply.workable.com/robeaute/